| Entry |
|
| Name |
Hydrocortisone butyrate (JP18/USP); Locoid (TN) |
| Product |
LOCOID (Bausch Health US), LOCOID LIPOCREAM (Bausch Health US), HYDROCORTISONE BUTYRATE (Oceanside Pharmaceuticals) |
| Generic |
HYDROCORTISONE BUTYRATE (Glenmark Pharmaceuticals), HYDROCORTISONE BUTYRATE (Lupin Pharmaceuticals), HYDROCORTISONE BUTYRATE (Mayne Pharma), HYDROCORTISONE BUTYRATE (Oceanside Pharmaceuticals), HYDROCORTISONE BUTYRATE (Oceanside Pharmaceuticals), HYDROCORTISONE BUTYRATE (Taro Pharmaceuticals U.S.A.), HYDROCORTISONE BUTYRATE (Teligent Pharma), HYDROCORTISONE BUTYRATE (Sola Pharmaceuticals) |
| Formula |
C25H36O6
|
| Exact mass |
432.2512
|
| Mol weight |
432.5497
|
| Structure |

|
| Simcomp |
|
| Class |
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
|
| Remark |
| Therapeutic category: | 2646 |
| ATC code: | A01AC03 A07EA02 C05AA01 D07AA02 D07AB02 D07XA01 H02AB09 S01BA02 S01CB03 S02BA01 |
| Chemical structure group: | DG00012 |
| Product (DG00012): | D00088<JP/US> D00165<US> D00977<JP> D00978<JP/US> D01619<JP/US> D01886<JP/US> D02288<US> |
|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
| Disease |
Atopic dermatitis [DS:H01358] Seborrheic dermatitis [DS:H01652] |
| Target |
NR3C1 (GR) [HSA:2908] [KO:K05771] |
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
| Metabolism |
Enzyme: CYP3A [HSA:1576 1577 1551]
|
| Interaction |
|
| Structure map |
| map07225 | Glucocorticoid and mineralocorticoid receptor agonists/antagonists |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A01 STOMATOLOGICAL PREPARATIONS
A01A STOMATOLOGICAL PREPARATIONS
A01AC Corticosteroids for local oral treatment
A01AC03 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally
A07EA02 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA Corticosteroids
C05AA01 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AA Corticosteroids, weak (group I)
D07AA02 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
D07AB Corticosteroids, moderately potent (group II)
D07AB02 Hydrocortisone butyrate
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07XA Corticosteroids, weak, other combinations
D07XA01 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB09 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA02 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01CB03 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
S02 OTOLOGICALS
S02B CORTICOSTEROIDS
S02BA Corticosteroids
S02BA01 Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatitis and Pruitus Agents
Glucocorticoids, Low Potency
Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP)
Glucocorticoids, Medium Potency
Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP)
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP)
Inflammatory Bowel Disease Agents
Glucocorticoids
Hydrocortisone
D01619 Hydrocortisone butyrate (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
2646 Adrenocorticotropic hormones
D01619 Hydrocortisone butyrate (JP18/USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
D01619 Hydrocortisone butyrate (JP18/USP)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Hydrocortisone butyrate
D01619 Hydrocortisone butyrate (JP18/USP)
Second-class OTC drugs
Inorganic and organic chemicals
Hydrocortisone butyrate
D01619 Hydrocortisone butyrate (JP18/USP)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00012 Hydrocortisone
D01619 Hydrocortisone butyrate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG00012 Hydrocortisone
D01619 Hydrocortisone butyrate
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D01619 Hydrocortisone butyrate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D01619 Hydrocortisone butyrate (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01619 Hydrocortisone butyrate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01619
Topical steroids potency [br08317.html]
Classification in the USA
D01619
Classification in Japan
D01619
Rx-to-OTC switch list in Japan [br08314.html]
D01619
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00012 Hydrocortisone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG00012 Hydrocortisone
|
| Other DBs |
|
| KCF data |
ATOM 31
1 C1z C 23.4455 -15.4741
2 C1y C 23.4632 -16.8359
3 C1z C 24.6253 -14.7814
4 C1x C 22.2892 -14.7991
5 C1y C 22.3069 -17.5227
6 C1x C 25.8286 -16.8824
7 C1x C 25.8169 -15.4506
8 C5a C 24.6136 -13.4138
9 O7a O 25.9754 -14.4939
10 C1y C 21.0976 -15.4918
11 C1y C 21.1036 -16.8476
12 C1x C 22.3069 -18.8845
13 C1b C 25.8581 -12.7564
14 O5a O 23.3868 -12.7035
15 O1a O 19.8767 -14.7874
16 C1z C 19.9472 -17.5285
17 C1x C 21.1270 -19.5712
18 O1a O 27.0672 -13.5018
19 C2y C 19.9590 -18.8963
20 C1x C 18.7614 -16.8594
21 C2x C 18.7732 -19.5889
22 C1x C 17.5758 -17.5402
23 C5x C 17.5581 -18.9783
24 O5x O 16.3665 -19.6182
25 C7a C 27.1852 -15.1923
26 C1b C 28.3980 -14.4902
27 C1b C 29.6109 -15.1923
28 C1a C 30.8237 -14.4902
29 O6a O 27.1860 -16.5967
30 C1a C 23.3905 -14.2074
31 C1a C 19.9850 -16.2632
BOND 34
1 3 8 1 #Up
2 3 9 1 #Down
3 4 10 1
4 5 11 1
5 5 12 1
6 8 13 1
7 8 14 2
8 10 15 1 #Up
9 11 16 1
10 12 17 1
11 13 18 1
12 16 19 1
13 16 20 1
14 19 21 2
15 20 22 1
16 21 23 1
17 23 24 2
18 6 7 1
19 10 11 1
20 17 19 1
21 22 23 1
22 9 25 1
23 1 2 1
24 25 26 1
25 1 3 1
26 26 27 1
27 1 4 1
28 27 28 1
29 2 5 1
30 25 29 2
31 2 6 1
32 1 30 1 #Up
33 3 7 1
34 16 31 1 #Up
|